| (210) | Number of the EPO application | 18710740 |
| (220) | Filing date of the EPO application | 2018.03.01 |
| (80) | EPO patent specification publication (B) | EPB nr. 41/2021, 2021.10.13 |
| (110) | EPO patent number | 3589274 |
| (21) | Number of the application | e 2020 0059 |
| (71) | Name(s) of applicant(s), code of the country | Arena Pharmaceuticals, Inc., US; |
| (72) | Name(s) of inventor(s), code of the country | SHAO Zezhi Jesse, US;
FLORIDA Raizza Berania, US;
LI Ching-Yuan, US;
SELVEY Lee Alani, US; |
| (73) | Name(s) of owner(s), code of the country | ARENA Pharmaceuticals Inc., US; |
| (54) | Title of the invention | COMPOSITIONS COMPRISING PGI2-RECEPTOR AGONISTS AND PROCESSES FOR THE PREPARATION THEREOF |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | A61K 9/20 (2006.01.01); A61K 31/27 (2006.01.01); A61K 9/16 (2006.01.01); A61K 9/28 (2006.01.01); A61K 9/48 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2020.02.29 |
| (30) | Priority | 201762465675 P, 2017.03.01, US; 201762468832 P, 2017.03.08, US; 201762526039 P, 2017.06.28, US; 201762530515 P, 2017.07.10, US |
| (86) | International application | PCT/US2018/020519, 2018.03.01 |
| (87) | International publication | WO 2018/160882, 2018.09.07 |